ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,017,202 | -18.2% | 298,370 | +8.6% | 0.02% | -14.3% |
| Q2 2023 | $9,797,831 | +16.7% | 274,696 | -16.9% | 0.02% | +5.0% |
| Q1 2023 | $8,398,713 | -34.7% | 330,658 | +4.3% | 0.02% | -39.4% |
| Q4 2022 | $12,862,833 | +53.8% | 317,131 | +25.3% | 0.03% | +43.5% |
| Q3 2022 | $8,365,000 | +9.9% | 253,126 | +17.1% | 0.02% | +21.1% |
| Q2 2022 | $7,613,000 | -44.7% | 216,205 | -27.8% | 0.02% | +26.7% |
| Q1 2022 | $13,768,000 | +17.4% | 299,380 | +69.2% | 0.02% | -40.0% |
| Q4 2021 | $11,731,000 | +20.8% | 176,925 | +13.7% | 0.02% | 0.0% |
| Q3 2021 | $9,714,000 | -6.0% | 155,589 | +24.6% | 0.02% | -13.8% |
| Q2 2021 | $10,339,000 | +37.2% | 124,836 | +9.8% | 0.03% | +11.5% |
| Q1 2021 | $7,537,000 | +56.4% | 113,659 | +81.0% | 0.03% | +44.4% |
| Q4 2020 | $4,818,000 | +102.4% | 62,794 | +13.6% | 0.02% | +50.0% |
| Q3 2020 | $2,380,000 | +37.9% | 55,269 | +38.3% | 0.01% | +20.0% |
| Q2 2020 | $1,726,000 | +117.1% | 39,974 | +44.7% | 0.01% | +66.7% |
| Q1 2020 | $795,000 | -43.5% | 27,633 | +24.5% | 0.01% | -33.3% |
| Q4 2019 | $1,408,000 | +88.5% | 22,190 | -16.2% | 0.01% | +80.0% |
| Q3 2019 | $747,000 | +262.6% | 26,494 | +241.4% | 0.01% | +400.0% |
| Q2 2019 | $206,000 | – | 7,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |